Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Ritalin La Generic Name & Formulations
Legal Class
CII
General Description
Methylphenidate HCl 10mg, 20mg, 30mg, 40mg; ext-rel caps (one-half as immediate-release + one-half as enteric-coated, delayed-release beads).
Pharmacological Class
CNS stimulant.
See Also
How Supplied
Caps, tabs—100
Manufacturer
Generic Availability
YES
Ritalin La Indications
Indications
Attention deficit hyperactivity disorder.
Ritalin La Dosage and Administration
Adults and Children
<6yrs: not established. Swallow whole or sprinkle contents onto applesauce (swallow immediately); do not crush, chew, or divide beads. ≥6yrs: initially 20mg once daily in the AM, may increase by 10mg weekly; max 60mg/day. Switching from other methylphenidate products: see full labeling.
Ritalin La Contraindications
Contraindications
During or within 14 days of MAOIs.
Ritalin La Boxed Warnings
Boxed Warning
Abuse and dependence.
Ritalin La Warnings/Precautions
Warnings/Precautions
High potential for abuse and dependence: monitor. Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors of developing a manic episode prior to initiation. Consider discontinuing if new psychotic/manic symptoms occur. Peripheral vasculopathy, including Raynaud's Phenomenon; monitor for digital changes. Monitor growth (esp. children), BP, HR. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Pregnancy. Nursing mothers: monitor infants.
Ritalin La Pharmacokinetics
See Literature
Ritalin La Interactions
Interactions
See Contraindications. Hypertensive crisis with MAOIs. Avoid concomitant use with halogenated anesthetics (eg, halothane, isoflurane), alcohol. May antagonize antihypertensive drugs (eg, K+-sparing or thiazide diuretics, CCBs, ACE inhibitors, ARBs, beta blockers, centrally acting alpha-2 receptor agonists); monitor and adjust dose of antihypertensives as needed. Concomitant risperidone may increase risk of extrapyramidal symptoms; monitor.
Ritalin La Adverse Reactions
Adverse Reactions
Headache, insomnia, abdominal pain, decreased appetite, anorexia, tachycardia, palpitations, anxiety, hyperhidrosis, weight loss, dry mouth, nausea; priapism, hypertension.
Ritalin La Clinical Trials
See Literature
Ritalin La Note
Not Applicable
Ritalin La Patient Counseling
See Literature
Images
